PATENT CLAIM ANALYSIS

Application Number: 15896285
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["546", "094000"]

Abstract:
The disclosure includes compounds of Formula (I) wherein Z 1 , Z 2 , Z 3 , X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7  are defined herein. Also disclosed is a method for treating HBV infection.

Claim (Index 8):
The compound or pharmaceutically acceptable salt thereof according to  claim 1 , wherein the compound is

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.6
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15706980', '15645067', '13392955', '11451074', '11451541']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.838501925774579
- 35 USC 102 Novelty (BERT): 0.5487225235124795
- Combined Prediction Score: 0.8095239855483691
- Mean Citation Score: 392.192572
- Max Citation Score: 414.2261
- Similarity Product: 376.3251590620935

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test